1. Home
  2. BCYC vs AAM Comparison

BCYC vs AAM Comparison

Compare BCYC & AAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • AAM
  • Stock Information
  • Founded
  • BCYC 2009
  • AAM 2024
  • Country
  • BCYC United Kingdom
  • AAM United States
  • Employees
  • BCYC N/A
  • AAM N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • AAM
  • Sector
  • BCYC Health Care
  • AAM
  • Exchange
  • BCYC Nasdaq
  • AAM Nasdaq
  • Market Cap
  • BCYC 566.5M
  • AAM 453.8M
  • IPO Year
  • BCYC 2019
  • AAM 2024
  • Fundamental
  • Price
  • BCYC $8.22
  • AAM $10.38
  • Analyst Decision
  • BCYC Buy
  • AAM
  • Analyst Count
  • BCYC 10
  • AAM 0
  • Target Price
  • BCYC $25.00
  • AAM N/A
  • AVG Volume (30 Days)
  • BCYC 333.0K
  • AAM 39.4K
  • Earning Date
  • BCYC 05-01-2025
  • AAM 01-01-0001
  • Dividend Yield
  • BCYC N/A
  • AAM N/A
  • EPS Growth
  • BCYC N/A
  • AAM N/A
  • EPS
  • BCYC N/A
  • AAM 0.30
  • Revenue
  • BCYC $25,722,000.00
  • AAM N/A
  • Revenue This Year
  • BCYC N/A
  • AAM N/A
  • Revenue Next Year
  • BCYC $1.83
  • AAM N/A
  • P/E Ratio
  • BCYC N/A
  • AAM $34.64
  • Revenue Growth
  • BCYC N/A
  • AAM N/A
  • 52 Week Low
  • BCYC $6.10
  • AAM $9.96
  • 52 Week High
  • BCYC $28.67
  • AAM $10.43
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 49.16
  • AAM N/A
  • Support Level
  • BCYC $8.00
  • AAM N/A
  • Resistance Level
  • BCYC $8.73
  • AAM N/A
  • Average True Range (ATR)
  • BCYC 0.48
  • AAM 0.00
  • MACD
  • BCYC 0.02
  • AAM 0.00
  • Stochastic Oscillator
  • BCYC 33.33
  • AAM 0.00

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About AAM AA Mission Acquisition Corp. Class A Ordinary Shares

AA Mission Acquisition Corp is a blank check company.

Share on Social Networks: